Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NSAID gastropathy. The central issue.

S H Roth1

  • 1Arthritis Center, Phoenix, Arizona.

Drugs
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Nonsteroidal anti-inflammatory drug (NSAID) gastropathy poses significant public health risks. Nabumetone shows promise as a new generation of gastro-protective NSAIDs, potentially reducing gastrotoxicity and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whose pain is it anyhow?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Finessing fibromyalgia.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2006
Same author

Anoxic depolarization of rat hippocampal slices is prevented by thiopental but not by propofol or isoflurane.

British journal of anaesthesia·2005
Same author

Small-dose pentobarbital enhances synaptic transmission in rat hippocampus.

Anesthesia and analgesia·2001
Same author

Arthritis therapy: a better time, a better day.

Rheumatology (Oxford, England)·2001
Same author

Effects of repeated hydrogen sulphide (H2S) exposure on learning and memory in the adult rat.

Neurotoxicology·2001

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Internal Medicine

Background:

  • NSAID gastropathy is a common and serious iatrogenic condition with significant public health implications.
  • Ulcer bleeding and perforation are potential disastrous outcomes of NSAID use.
  • Current gastroprotective therapies face challenges with patient compliance due to lack of predictive symptoms and high costs.

Purpose of the Study:

  • To evaluate nabumetone as a potential prototype for a new generation of gastro-sparing NSAID therapies.
  • To explore strategies for reducing NSAID-induced gastrotoxicity.
  • To address the underestimation of NSAID gastropathy in clinical practice.

Main Methods:

  • Review of postmarketing surveillance data.
  • Analysis of clinical research findings.

Related Experiment Videos

  • Endoscopy evaluations of NSAID-induced gastrointestinal effects.

    • Main Results:

    • Nabumetone exhibits desirable pharmacological features for gastroprotection.
    • Encouraging evidence suggests nabumetone's potential as a gastro-sparing NSAID.
    • Current clinical data supports nabumetone's role in reducing gastrotoxicity.

    Conclusions:

    • Nabumetone represents a potential advancement in NSAID therapy, offering gastroprotective benefits.
    • A treatment strategy focused on reducing NSAID gastrotoxicity is a primary clinical goal.
    • Nabumetone may serve as a prototype for future gastro-sparing NSAID development.